Novartis's office in Spain: E Madrid, Spain

Business Address: Bexal Farmacéutica S.A., Calle Serrano Galvache 56, Parque Empresarial Parque Norte, E-28033 Madrid, Spain

Phone: 34 91 548 8404

Fax: 34 91 740 1408

Web: https://www.bexal.es

Type Public (Aktiengesellschaft)
Traded as
ISIN  
Industry Pharmaceuticals
Predecessors
  • Ciba-Geigy
  • Sandoz (via merger)
Founded
  • March 1996 (1996-03)
  • (from merger)
Founders
  • Johann Rudolf
  • Alexander Clavel
Headquarters
  • Basel, Switzerland
  • Cambridge, Massachusetts, United States (global research)
Area served Worldwide
Key people Vasant Narasimhan (CEO)
Products Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)
Revenue Increase US$51.63 billion (2021)
Operating income Increase US$11.69 billion (2021)
Net income Decrease US$24.02 billion (2021)
Total assets Increase US$131.79 billion (2021)
Total equity Increase US$67.82 billion (2021)
Number of employees Steady 110,000 (2021)
Website www.novartis.com

Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.

Other Novartis's locations in Spain

Novartis's locations around the world

China
United States
Subskrybuj